Drug Availability Update


HPS Pharmacies wish to give notice that Merck Sharp & Dohme Australia Pty Ltd are experiencing an interruption to the supply of Emend® capsules as follows:

Emend® Capsules
Aprepitant 165mg
ARTG 182320

Normal supplies are expected to resume in mid-September 2017.

While no generic equivalent medicine is currently registered in Australia, HPS Pharmacies advise that internationally registered products will be available in around seven days. Access will be under the Special Access Scheme for immediate supply to seriously ill patients, pending completion and forwarding of the Category A SAS form by the medical practitioner. Non-urgent supplies require completion of a Category B form, and approval by the TGA prior to use.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Merck Sharp & Dohme Australia on 1800 678 883.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates